Intravenous Immunoglobulin and Rituximab in HLA Highly Sensitized Kidney Transplant Recipients

HLA-sensitized patients are penalized both in the access to kidney transplantation (KT) and, once transplanted, in the incidence of rejections and long-term allograft survival despite aggressive induction and maintenance therapy.

Source: Transplantation Proceedings - April 1, 2018 Category: Transplant Surgery Authors: S. Querido, A. Weigert, T. Adrag ão, J. Henriques, R. Birne, P. Matias, C. Jorge, C. Nascimento, M. Bruges, D. Machado Tags: 15th Brazilian Transplantation Congress and 16th Portuguese-Brazilian Transplantation Congress Source Type: research